1. What Sanofi might buy with its Regeneron windfall — Gilead pens $2B Arcus pact for immuno-oncology targets — FDA approves BMS Opdivo + Yervoy combo for first-line on certain types of NSCLC — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Anesthesia Division

Discussion in 'Teleflex Medical' started by Anonymous, Jun 21, 2015 at 5:50 PM.

  1. Anonymous

    Anonymous Guest

    Anyone thinking of coming to work here- don't. This division has become toxic since the realignment in December. Unrealistic expectations, micro-management and constant back-orders and recalls. On top of all that, when we have a recall, they don't back the recalled product out of our numbers.
  2. Anonymous

    Anonymous Guest

    Hey yo-yo....no company backs out recalled products.....you got paid on it last year so deal with it and sell something else!
  3. anonymous

    anonymous Guest

    What does getting paid on something I sold last year have to do with something that's not available to sell this year? Makes about as much sense as the shit products in our bag. Night Gracie